德展健康
(000813)
| 流通市值：64.94亿 | | | 总市值：64.95亿 |
| 流通股本：21.65亿 | | | 总股本：21.65亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 354,472,693.3 | 248,317,627.03 | 101,250,441.65 | 498,088,171.28 |
| 营业收入 | 354,472,693.3 | 248,317,627.03 | 101,250,441.65 | 498,088,171.28 |
| 二、营业总成本 | 333,494,551.73 | 225,262,951.49 | 106,513,804.78 | 468,292,393.88 |
| 营业成本 | 136,624,067.32 | 97,426,800.22 | 49,031,282.39 | 205,535,638.92 |
| 税金及附加 | 8,350,475.34 | 5,905,962.07 | 3,082,810.83 | 11,467,467.09 |
| 销售费用 | 61,587,510.18 | 40,173,352.45 | 16,885,140.89 | 91,603,136.08 |
| 管理费用 | 141,503,107.32 | 93,214,413.92 | 43,556,468.32 | 173,559,265.33 |
| 研发费用 | 36,148,711.02 | 22,656,175.7 | 10,877,646.84 | 51,095,963.9 |
| 财务费用 | -50,719,319.45 | -34,113,752.87 | -16,919,544.49 | -64,969,077.44 |
| 其中:利息费用 | 283,269.54 | 191,139.08 | 97,332.9 | 365,894.26 |
| 其中:利息收入 | 51,084,143.81 | 34,355,969.96 | 17,047,087.43 | 68,006,940.85 |
| 加:投资收益 | -10,162,176.84 | -7,855,961.55 | -1,775,111.21 | 80,311,589.36 |
| 资产处置收益 | -3,216.54 | -3,216.54 | - | -34,109.82 |
| 资产减值损失(新) | -449,442.05 | -120,632.75 | -23,412.26 | -21,990,168.41 |
| 信用减值损失(新) | -13,340,597.34 | -10,321,834.63 | -10,610,955.45 | -12,570,742.93 |
| 其他收益 | 2,986,924.45 | 2,105,793.76 | 1,049,674.97 | 4,711,536.08 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 9,633.25 | 6,858,823.83 | -16,623,167.08 | 80,223,881.68 |
| 加:营业外收入 | 14,518.24 | 6,321.83 | 11,435.06 | 3,002,081.9 |
| 减:营业外支出 | 986,186.64 | 963,836.99 | 873,648.47 | 1,385,170.22 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -962,035.15 | 5,901,308.67 | -17,485,380.49 | 81,840,793.36 |
| 减:所得税费用 | 7,367,120.87 | 6,552,066.73 | 4,128,511.06 | 27,599,099.84 |
| 六、净利润 | -8,329,156.02 | -650,758.06 | -21,613,891.55 | 54,241,693.52 |
| 持续经营净利润 | -8,329,156.02 | -650,758.06 | -21,613,891.55 | 54,241,693.52 |
| 归属于母公司股东的净利润 | 8,089,554.12 | 10,152,636.38 | -16,805,072.84 | 83,314,246.81 |
| 少数股东损益 | -16,418,710.14 | -10,803,394.44 | -4,808,818.71 | -29,072,553.29 |
| (一)基本每股收益 | 0 | 0 | -0.01 | 0.04 |
| (二)稀释每股收益 | 0 | 0 | -0.01 | 0.04 |
| 八、其他综合收益 | - | - | - | -2,125,000 |
| 归属于母公司股东的其他综合收益 | - | - | - | -2,125,000 |
| 九、综合收益总额 | -8,329,156.02 | -650,758.06 | -21,613,891.55 | 52,116,693.52 |
| 归属于母公司股东的综合收益总额 | 8,089,554.12 | 10,152,636.38 | -16,805,072.84 | 81,189,246.81 |
| 归属于少数股东的综合收益总额 | -16,418,710.14 | -10,803,394.44 | -4,808,818.71 | -29,072,553.29 |
| 公告日期 | 2024-10-31 | 2024-08-28 | 2024-04-25 | 2024-04-12 |
| 审计意见(境内) | | | | 标准无保留意见 |